EGF Theramed Health (TSE:TMED)

:TMED

TMED

EGF Theramed Health

RESEARCH TOOLSreports

Want to see TSE:TMED full AI Analyst Report?

EGF Theramed Health (TMED) Price & Analysis

6 Followers

TMED Stock Chart & Stats

C$0.07

C$0.00(0.00%)

At close: Dec 30 4:00 PM EST

C$0.07

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.06 - C$0.13

Previous CloseN/A

Volume0.00

Average Volume (3M)1.23K

Market Cap

C$929.33K

Enterprise ValueC$2.30M

Total Cash (Recent Filing)C$10.47K

Total Debt (Recent Filing)C$1.63M

Price to Earnings (P/E)―

Beta0.45

Next Earnings

Jun 02, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding11,616,665

10 Day Avg. Volume1,800

30 Day Avg. Volume1,233

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)-0.26

Price to Sales (P/S)0.00

P/FCF Ratio38.98

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Improving Cash GenerationA shift to slightly positive operating and free cash flow in 2025 indicates the business has begun generating some internal cash. If sustained, even modest cash generation can extend runway, reduce near-term financing pressure, and provide time to execute commercialization or restructure plans.

Improving Loss TrajectoryA multi-year reduction in reported net losses from the extreme 2020 level to smaller losses through 2021–2024 suggests management has been able to materially cut burn or right-size operations. This trend enhances the prospect of reaching an earnings base if cost discipline and strategic focus continue.

Industry ExposureBeing positioned in healthcare information services aligns the company with long-term secular demand for digital health, analytics, and data-enabled care. Structural tailwinds expand the addressable market and offer durable commercial opportunities if the company can develop competitive offerings and penetrate customers.

Bears Say

No Reported RevenueThe absence of reported revenue across all years indicates no demonstrated commercial product-market fit or recurring sales. Without revenue, the firm remains entirely reliant on external financing, which undermines long-term viability and increases execution risk until monetization is proven.

Stressed Balance SheetNegative equity, a very small asset base and meaningful debt reflect acute solvency strain and limited financial flexibility. This elevates the probability of recapitalization or dilution, constrains investment in product development or commercialization, and reduces ability to withstand adverse shocks.

Persistent Losses & Volatile Cash FlowSustained operating losses and volatile free cash flow—even with a small 2025 uptick—impede reliable capital allocation and long-term planning. Persistent negative operating margins increase the need for frequent external funding, raising execution and dilution risks for strategic initiatives.

EGF Theramed Health News

EGF Theramed refreshes board and finance leadership

EGF Theramed Health ( ($TSE:TMED) ) has shared an announcement. EGF Theramed Health Corp. has appointed Lin Ye...

2M ago

TMED FAQ

What was EGF Theramed Health’s price range in the past 12 months?

EGF Theramed Health lowest stock price was C$0.06 and its highest was C$0.13 in the past 12 months.

What is EGF Theramed Health’s market cap?

EGF Theramed Health’s market cap is C$929.33K.

When is EGF Theramed Health’s upcoming earnings report date?

EGF Theramed Health’s upcoming earnings report date is Jun 02, 2026 which is in 32 days.

How were EGF Theramed Health’s earnings last quarter?

EGF Theramed Health released its earnings results on Feb 24, 2026. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.

Is EGF Theramed Health overvalued?

According to Wall Street analysts EGF Theramed Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does EGF Theramed Health pay dividends?

EGF Theramed Health does not currently pay dividends.

What is EGF Theramed Health’s EPS estimate?

EGF Theramed Health’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does EGF Theramed Health have?

EGF Theramed Health has 11,616,665 shares outstanding.

What happened to EGF Theramed Health’s price movement after its last earnings report?

EGF Theramed Health reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of EGF Theramed Health?

Currently, no hedge funds are holding shares in TSE:TMED

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

EGF Theramed Health

EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.